Status: Recruiting
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome
This is a single-center, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of L-fucose supplementation in subjects with GLUT1 deficiency syndrome (GLUT1DS).
Participants needed: 16
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Oregon Health and Science UniversityUpdated: May 13, 2026Locations: 1
Eligibility criteria
Age ≥ 18 years [+2]
Inability to swallow liquids [+9]